Silvia Taylor | SVP, Global Corporate Affairs & IR |
Stan Erck | President, CEO |
John Trizzino | EVP & Chief Business & Commercial Officer |
Filip Dubovsky | EVP & Chief Medical Officer |
James Kelly | EVP, CFO & Treasurer |
Greg Glenn | President, Research and Development |
Roger Song | Jefferies |
Georgi Yordanov | Cowen and Company |
Eric Joseph | JPMorgan |
Mayank Mamtani | B. Riley Securities |
Vernon Bernardino | H.C. Wainright |
Good afternoon, and welcome to the Novavax First Quarter 2022 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Silvia Taylor, Senior Vice President of Global Corporate Affairs and Investor Relations. Please go ahead.
Good afternoon, and thank you all for joining us today to discuss our first quarter 2022 operational highlights and financial results.